ARTICLE | Clinical News
Alpha-tocopherol quinone: Phase IIa started
February 15, 2010 8:00 AM UTC
Penwest began a double-blind, placebo-controlled, U.K. Phase IIa trial in 30 patients to evaluate A0001 for 28 days. Penwest has exclusive, worldwide rights to develop and commercialize A0001 from Edi...